This lunch symposium features Dr. Milan Patel from MD Anderson Cancer Center, who will review the clinical application of Stryker's SpineJack system for cancer‑related vertebral compression fractures. The session will examine current evidence supporting percutaneous vertebral augmentation in oncology patients, with emphasis on pain reduction, mechanical stabilization and functional outcomes. Dr. Patel will outline patient‑selection criteria, procedural considerations, and post‑treatment expectations, integrating case examples to illustrate real‑world decision‑making. Participants will gain a clearer understanding of how SpineJack may fit within multidisciplinary cancer care pathways and its potential role in improving quality of life for patients with metastatic spinal involvement.